Contribution of tumor necrosis factor alpha to the pathogenesis of stroke

• Autorzy: Zaremba J
• Języki publikacji: EN

Abstrakty

EN

Tumor necrosis factor alpha (TNF-alpha) is a protein of a cellular origin belonging to a group of proinflammatory cytokines. A rapid overproduction of TNF-alpha in a cerebral post-ischemic inflammatory response leads to the stimulation of adhesive molecules expression with subsequent accumulation of leukocytes in the ischemic focus, which is preceded by their adhesion and migration. The TNF-alpha proinflammatory activity results mainly in extending the area of the brain infarct, which brings about negative clinical implications. Being the final morphological effect of ischemic stroke, TNF-alpha appears also to contribute to neuronal necrosis by its involvement in the process of apoptosis as well as in the death of neurons. The present study describes and discusses mainly the contribution of TNF-alpha to the formation of ischemic focus in the brain.

Słowa kluczowe

EN

neuroimmunology; pathogenesis; stroke; tumour necrosis factor-alpha; cytokine; proinflammatory cytokine

• Wydawca: -
• Czasopismo: Folia Morphologica
• Rocznik: 2000
• Tom: 59
• Numer: 3
• Opis fizyczny: p.137-143

Twórcy

autor

Zaremba J

• University Medical School, Przybyszewskiego 49, 60-355 Poznan, Poland

Bibliografia

• 1. Aggrarwal BB, Puri RK (1995) Human cytokines: Their role in disease and therapy. Blackwell Science, Cambridge, MA.
• 2. Anwaar I, Gottsater A, Ohlsson K, Mattiasson I, Lindgarde F (1998) Increasing levels of leukocyte-derived inflammatory mediators in plasma and camp in platelets during follow-up after acute cerebral ischemia. Cerebrovasc Dis, 8: 310–317.
• 3. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ (1997) Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke, 28: 1233–1244.
• 4. Barone FC, Feuerstein GZ (1999) Inflammatory mediators and stroke: New opportunities for novel therapeutics. J Cereb Blood Flow Metab, 19: 819–834.
• 5. Bertorelli R, Adami M, Di-Santo E, Ghezzi P (1998) MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain. Neurosci-Lett., 246: 41–44.
• 6. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr. (1985) Interleukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J Clin Invest, 76: 2003–2011.
• 7. Brosnan CF (1995) Cytokine localization in multiple sclerosis lesions: Correlation with adhesion molecule expression and reactive nitrogen species. Neurology, Suppl. 6: 16–21.
• 8. Buttini M, Appel K, Sauter A, Gebicke-Haerter PJ, Boddeke HW (1996) Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience, 71: 1–16.
• 9. Catania A, Lipton JM (1998) Peptide modulation of fever and inflammation within the brain. Ann N Y Acad Sci, 856: 62–68.
• 10. DeGraba TJ (1998) The role of inflammation after acute stroke: Utility of pursuing anti-adhesion molecule therapy. Neurology, 51: 62–68.
• 11. Dekkers PE, Levi M, van Deventer SJ, van der Poll T (1999) Divergent roles of tumor necrosis factor and platelet-activating factor in endotoxin-induced release of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1 beta in chimpanzees. Infect Immun, 67: 5480–5482.
• 12. Elneihoum AM, Falke P, Axelsson L, Lundberg E, Lindgarde F, Ohlsson K (1996) Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke, 27: 1734–1738.
• 13. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M (1994) Proinflammatory cytokines in serum of patients with acute cerebral ischemia: Kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci, 122: 135–139.
• 14. Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, Sarinella F, Frattola L, De Simoni MG (1999) Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab, 19: 1004–1009.
• 15. Feuerstein GZ, Liu T, Barone FC (1994) Cytokines, inflammation and brain injury: Role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev, 6: 341–360.
• 16. Feuerstein GZ, Wang X, Barone FC (1997) Inflammatory gene expression in cerebral ischemia and trauma. Potential new therapeutic targets. Ann N Y Acad Sci, 825: 179–193.
• 17. Feuerstein G, Wang X, Barone FC (1998) Cytokines in brain ischemia — the role of TNF-alpha. Cell Mol Neurobiol, 18: 695–701.
• 18. Frei K, Siepl C, Groscurth P, Bodmer P, Schwerdel C, Fontana A (1987) Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol, 17: 1271–1278.
• 19. Garcia JH, Liu KF, Yoshida Y, Lian J, Chen S, Del Zoppo GJ (1997) Influx of leukocytes and platelets in an evolving brain infarct /Wistar rat/. Am J Pathol, 144: 188–199.
• 20. Goeddel DV, Aggrarwal BB, Gray PW, Leung DW, Nedwin GE, Palladino MA, Patton JS, Pennica D, Shepard HM, Sugarman BJ, Wong GHW (1986) Tumor necrosis factors: Gene structure and biological activities. Cold Spring Harbor Symp Quant Biol, 51: 597–609.
• 21. Gong C, Qin Z, Betz AL, Liu XH, Yang GY (1998) Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice. Brain Res, 801: 1–8.
• 22. Gourmala NG, Limonta S, Bochelen D, Sauter A, Boddeke HW (1999) Localization of macrophage inflammatory protein: Macrophage inflammatory protein-1 expression in rat brain after peripheral administration of lipopolysaccharide and focal cerebral ischemia. Neuroscience, 88: 1255–1266.
• 23. Guo H, Jin YX, Ishikawa M, Huang YM, van der Meide PH, Link H, Xiao BG (1998) Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysacharide, proinflammatory and immunoregulatory cytokines. Scand J Immunol, 48: 502–508.
• 24. Hallenbeck JM, Dutka AJ, Kochanek PM, Siren AL, Pezeshkpour GH, Feuerstein G (1988) Stroke risk factors prepare rat brainstem tissues for modified local shwartzman reaction. Stroke, 19: 863–869.
• 25. Hallenbeck JM, Dutka AJ, Vogel SN, Heldman E, Doron DA, Feuerstein G (1991) Lipopolysaccharide-induced production of tumor necrosis factor activity in rats with and without risk factors for stroke. Brain Res, 541: 115–120.
• 26. Hallenbeck JM, Frerichs KU (1993) Stroke therapy. It may be time for an integrated approach. Arch Neurol, 50: 768–770.
• 27. Hallenbeck JM (1997) Cytokines, macrophages, and leukocytes in brain ischemia. Neurology, 49 (Suppl. 4): 5–9.
• 28. Haring H, Berg EL, Tsurushita N, Tagaya M, Del Zoppo GJ (1996) E-selectin appears in nonischemic tissue during experimental focal cerebral ischemia. Stroke, 27: 1386–1392.
• 29. Herr I, Martin-Villalba A, Kurz E, Roncaioli P, Schenkel J, Cifone MG, Debatin KM (1999) FK 506 prevents stroke-induced generation of ceramide and apoptosis signaling. Brain Res, 826: 210–219.
• 30. Hess DC, Bhutwala T, Sheppard JC, Zhao W, Smith J (1994) ICAM-1 expression on human brain microvascular endothelial cells. Neurosci-Lett, 168: 201–204.
• 31. Jakubisiak M (1995) Immunologia. PWN, Warszawa.
• 32. Jander S, Kraemer M, Schroeter M, Witte OW; Stoll G (1995) Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J Cereb Blood Flow Metab, 15: 42–51.
• 33. Jean WC, Spellman SR, Nussbaum ES, Low WC (1998) Reperfusion injury after focal cerebral ischemia: The role of inflammation and the therapeutic horizon. Neurosurgery, 43: 1382–1396.
• 34. Kim JS (1996) Cytokines and adhesion molecules in stroke and related diseases. J Neurol Sci, 137: 69–78.
• 35. Kol A, Sukhova GK, Lichtman AH, Libby P (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation, 98: 300–307.
• 36. Leker RR, Shohami E, Abramsky O, Ovadia H (1999) Dexanabinol; a Novel neuroprotective drug in experimental focal cerebral ischemia. J Neurol Sci, 162: 114–119.
• 37. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ (1994) Tumor necrosis factor-alpha expression in ischemic neurons. Stroke, 25: 1481–1488.
• 38. Maemura K, Kurihara H, Morita T, Oh-hashi Y, Yazaki Y (1992) Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology, 38 (Suppl. 1): 29–35.
• 39. Meistrell ME 3rd, Botchkina GI, Wang H, Di-Santo E, Cockroft KM, Bloom O, Vishnubhakat JM, Ghezzi P, Tracey KJ (1997) Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia. Shock, 8: 341–348.
• 40. Movat HZ, Burrowes CE, Cybulsky MI, Dinarello CA (1987) Acute inflammation and a Shwartzman-like Reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury. Am J Pathol, 129: 463–476.
• 41. Movat HZ, Burrowes CE, Cybulsky MI, Dinarello CA (1987) Role of complement, interleukin-1 and tumor necrosis factor in a local shwartzman-like reaction. In: Movat HZ (ed.). Leukocyte emigration and its sequelae. Karger, Basel, pp. 69–78.
• 42. Nawashiro H, Martin D, Hallenbeck JM (1997) Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J Cereb Blood Flow Metab, 17: 229–232.
• 43. Nawroth PP, Handley DA, Esmon CT, Stern DM (1986) Interleukin-1 induces endothelial cell procoagulant while supressing cell surface anticoagulant activity. Proc Natl Acad Sci USA, 83: 3460–3464.
• 44. Olsson T (1994) Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur J Neurol, 1: 7–19.
• 45. Peterson PK, Hu S, Salak-Johnson J, Molitor TW, Chao CC (1997) Differential production of and migratory response to beta chemokines by human microglia and astrocytes. J Infect Dis, 175: 478–481.
• 46. Ross R (1993) The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature, 362: 801–809.
• 47. Ross SA, Halliday MI, Campbell GC, Byrnes DP, Rowlands BJ (1994) The presence of tumor necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg, 8: 419–425.
• 48. Rothwell NJ, Loddick SA, Stroemer P (1997) Interleukins and cerebral ischemia. Int Rev Neurobiol, 40: 281–298.
• 49. Schwartz LM, Osborne BA (1993) Programmed cell death apoptosis and killer genes. Immunol today, 14: 582–590.
• 50. Selmaj K, Raine CS, Faroog M, Norton WT, Brosnan CF (1991) Cytokine cytotoxity against oligodendrocytes. Apoptosis Induced by lymphotoxin. J Immunol, 147: 1522.
• 51. Sharief MK, Thompson EJ (1992) In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol, 38: 27–34:
• 52. Shibatu M, Parfenova H, Zuckerman SL, Leffer CW (1996) Tumor necrosis factor-alpha induces pial arteriolar dilation in newborn pigs. Brain Res Bull, 39: 241–247.
• 53. Shimizu Y, Newman W, Tanaka Y, Shaw S (1992) Lymphocyte interactions with endothelial cells. Immunol today, 13: 106–112.
• 54. Siren AL, Heldman E, Doron D, Lysko PG, Yue TL, Liu Y, Feuerstein G, Hallenbeck JM (1992) Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Stroke, 23: 1643–1650.
• 55. Siren AL, Liu Y, Feuerstein G, Hallenbeck JM (1993) Increased release of tumor necrosis factor-alpha into the cerebrospinal fluid and peripheral circulation of aged rats. Stroke, 24: 880–886.
• 56. Takami S, Nishikawa H, Minami M, Nishiyori A, Sato M, Akaike A, Satoh M (1997) Induction of macrophage inflammatory protein MIP-1 alpha mRNA on glial cells after focal cerebral ischemia in the rat. NeurosciLett., 227: 173–176.
• 57. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A (1995) Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke, 26: 1393–1398.
• 58. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A (1997) Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol, 110: 492–499.
• 59. Tarkowski E, Rosengren L, Blomstrand C, Jensen C, Ekholm S, Tarkowski A (1999) Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke, 30: 321–327.
• 60. Tomimoto H, Akiguchi I, Wakita H, Kinoshita A, Ikemoto A, Nakamura S, Kimura J (1996) Glial expression of cytokines in the brains of cerebrovascular disease patients. Acta Neuropathol Berl, 92: 281–287.
• 61. Tseng MT, Chang CC (1999) Ultrastructural localization of hippocampal TNF-alpha immunoreactive cells in rats following transient global ischemia. Brain Res, 833: 121–124.
• 62. Tureen J (1995) Effect of recombinant human tumor necrosis factor-alpha on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: Role of Nitric Oxide. J Clin Invest, 9: 1086–1091.
• 63. Uno H, Matsuyama T, Akita H, Nishimura H, Sugita M (1997) Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab, 17: 491–499.
• 64. Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ (1994) Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol, 23: 103–114.
• 65. Wang X, Feuerstein GZ (1995) Induced expression of adhesion molecules following focal brain ischemia. J Neurotrauma, 12: 825–832.
• 66. Yang GY, Gong C, Qin Z, Ye W, Mao Y, Bertz AL (1998) Inhibition of TNF-alpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport, 9: 2131–2134.
• 67. Yang GY, Gong C, Qin Z, Liu XH, Lorris-Betz A (1999) Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain Res Mol Brain Res, 69: 135–143.
• 68. Youngs SJ, Ali SA, Taub DD, Rees RC (1997) Chemokines induce migrational responses in human breast carcinoma cell lines. Int J Cancer, 71: 257–266.
• 69. Zaremba J, Losy J Tumor necrosis factor alpha (tnf-alpha) in patients with stroke. In press.
• 70. Zhang RL, Chopp M, Li Y, Zaloga C, Jiang N, Jones ML (1994) Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology, 44: 1747–1751.